Presepsin value predicts the risk of developing severe/critical COVID-19 illness: results of a pooled analysis.

Lippi, Giuseppe; Sanchis-Gomar, Fabian; Henry, Brandon M

Lippi, Giuseppe; Sanchis-Gomar, Fabian; Henry, Brandon M.

Lippi G; Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Sanchis-Gomar F; Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain.
Henry BM; Cardiac Intensive Care Unit, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Clin Chem Lab Med ; 60(1): e1-e3, 2022 01 26.

Article in English | MEDLINE | ID: covidwho-1394583

Subject(s)

COVID-19; Lipopolysaccharide Receptors/blood; Peptide Fragments/blood; Biomarkers/blood; C-Reactive Protein/analysis; COVID-19/blood; COVID-19/diagnosis; Critical Illness; Humans

Keywords

COVID-19; biomarkers; coronavirus; presepsin

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Peptide Fragments / Lipopolysaccharide Receptors / COVID-19 Type of study: Diagnostic study / Prognostic study / Reviews Limits: Humans Language: English Journal: Clin Chem Lab Med Journal subject: Chemistry, Clinical / Laboratory Techniques and procedures Year: 2022 Document Type: Article Affiliation country: Cclm-2021-0848

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google